{"Title": "L-ornithine L-aspartate for people with cirrhosis and hepatic encephalopathy", "Year": 2016, "Source": "Cochrane Database Syst. Rev.", "Volume": "2016", "Issue": 10, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 2, "DOI": "10.1002/14651858.CD012410", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84992453039&origin=inward", "Abstract": "\u00a9 2016 The Cochrane Collaboration.This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of L-ornithine L-aspartate versus placebo, no intervention, or other active interventions for people with cirrhosis and hepatic encephalopathy.", "AuthorKeywords": null, "IndexKeywords": null, "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 2, "EID": "2-s2.0-84992453039", "SubjectAreas": [["Pharmacology (medical)", "MEDI", "2736"]], "AuthorData": {"8567814300": {"Name": "Stokes C.S.", "AuthorID": "8567814300", "AffiliationID": "60023686", "AffiliationName": "Saarland University Medical Centre, Department of Medicine II"}, "57191694624": {"Name": "Goh E.T.", "AuthorID": "57191694624", "AffiliationID": "60022148", "AffiliationName": "Division of Medicine, Royal Free Campus, University College London, UCL Institute for Liver and Digestive Health"}, "56765086300": {"Name": "Morgan M.Y.", "AuthorID": "56765086300", "AffiliationID": "60022148", "AffiliationName": "Division of Medicine, Royal Free Campus, University College London, UCL Institute for Liver and Digestive Health"}, "7004936517": {"Name": "Vilstrup H.", "AuthorID": "7004936517", "AffiliationID": "60023882", "AffiliationName": "Aarhus Kommunehospital, Department of Hepatology and Gastroenterology"}, "6507039741": {"Name": "Gluud L.L.", "AuthorID": "6507039741", "AffiliationID": "60002327", "AffiliationName": "Copenhagen University Hospital Hvidovre, Gastrounit, Medical Division"}}}